Following treatment of primary mouse-derived myotubes with 100 U/ml IFN-γ, β-galactosidase reporter activity at 2 and 4 days post infection was significantly reduced as compared to untreated controls (p<0.05; Students t-test; Fig. 2A). The gene discussed is IFNG; the disease is infection.